Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Rationale: Injury to alveolar epithelial cells is central to the pathophysiology of idiopathic pulmonary fibrosis (IPF). An abnormal autoimmune response directed against antigens of the alveolar epithelium may contribute to the disease. Objectives: To detect circulating autoantibodies (autoAbs) directed against epithelial structures. Methods: We performed immunoblot by separating human placental amnion extract or alveolar epithelial cell (A549 cell line) proteins on polyacrylamide gels, blotting on nitrocellulose membranes, and incubating with serum from patients with IPF (n = 40) or healthy subjects (n = 40). Proteomic analysis and mass spectrometry characterized the target protein. Inhibition experiments performed with the correspondent recombinant protein confirmed our results. Measurements and Main Results: We identified IgG autoAbs recognizing a 200-kD protein in the serum of patients with IPF. Proteomic analysis identified this protein as human periplakin (PPL), a component of desmosomes. Anti-PPL Abs were found by immunoblot in both serum and bronchoalveolar lavage in patients with IPF: 16/40 (40%) of them were positive versus none of the control subjects. Immunohistochemistry revealed that PPL was strongly expressed in bronchial and alveolar epithelium, but that PPL exhibited changes in intracellular localization among normal and fibrotic alveolar epithelium. In an alveolar epithelial wound repair assay, an anti-PPL IgG decreased cell migration. Recombinant PPL induced bronchoalveolar lavage T lymphocyte proliferation. Patients with IPF with anti-PPL Abs had a more severe respiratory disease, despite no difference in survival. Conclusions: We found a new circulating autoAb directed against PPL in patients with IPF, associated with a more severe disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A variety of novel autoantibodies targeting neoepitopes have been reported in IPF (159–163), with many of the targets being structural cell proteins, such as desmoplakin (164) and periplakin (159).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [159]
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia
Anhalt, G. J., Kim, S., Stanley, J. R., Korman, N. J., Jabs, D. A., Kory, M., Izumi, H., Ratrie, H., Mutasim, D., Ariss-Abdo, L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012203232503 · Cited by 1,035
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Kazerooni, E. A., Martinez, F. J., Flint, A., Jamadar, D. A., Gross, B. H., Spizarny, D. L., Cascade, P. N., Whyte, R. I., Lynch, J. P., & Toews, G. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.169.4.9308447 · Cited by 469 · cited 1×
“2 semiquantitative scoring of the extent of fibrosis and ground glass opacities was performed, as previously described by Kazerooni and colleagues [2].”
MethodProbst, C., Schlumberger, W., Stöcker, W., Recke, A., Schmidt, E., Hashimoto, T., Zhu, X. J., Zillikens, D., & Komorowski, L. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.08.022 · Cited by 406
Amagai, M., Nishikawa, T., Nousari, H. C., Anhalt, G. J., & Hashimoto, T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3647 · Cited by 312
The Mechanism of Respiratory Failure in Paraneoplastic Pemphigus
Nousari, H. C., Deterding, R., Wojtczack, H., Aho, S., Uitto, J., Hashimoto, T., & Anhalt, G. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401805 · Cited by 247
Immunopathology and molecular diagnosis of autoimmune bullous diseases
Mihai, S., & Sitaru, C. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00033.x · Cited by 214
Ruhrberg, C., Hajibagheri, M. A. N., Parry, D. A. D., & Watt, F. M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1835 · Cited by 210
Bhol, K., Natarajan, K., Nagarwalla, N., Mohimen, A., Aoki, V, & Ahmed, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5239 · Cited by 200
Research works printed but not linked: 38
- 2001, N Engl J Med, 517
- 2007, Am J Respir Crit Care Med, 1007
- 2006, J Immunol, 5735
- 2007, J Immunol, 2592
- 1994, Thorax, 218
- 1994, Thorax, 1139
- 2002, Clin Exp Immunol, 169
- 1998, Thorax, 969
- 1999, Lung, 311
- 2007, J Cell Mol Med, 462
- 2003, Br J Dermatol, 939
- 2010, Br J Dermatol, 743
- 2009, Am J Respir Crit Care Med, A2176
- 2000, Am J Respir Crit Care Med, 646
- 1997, AJR Am J Roentgenol, 977
- 2004, J Biol Chem, 22773
- 2004, Am J Physiol Lung Cell Mol Physiol, L448
- 1980, Cell Immunol, 205
- 1997, J Cell Biol, 1835
- 2002, Exp Dermatol, 428
- 1998, J Invest Dermatol, 1236
- 1990, N Engl J Med, 1729
- 1998, J Clin Invest, 775
- 1998, J Invest Dermatol, 503
- 2009, Chin Med J (Engl), 486
- 2009, Clin Chim Acta, 13
- 2004, Br J Dermatol, 1018
- 1999, N Engl J Med, 1406
- 2002, J Cell Sci, 5027
- 2006, J Cell Sci, 5147
- 2002, J Cell Sci, 3957
- 2004, Proc Natl Acad Sci USA, 10392
- 2001, J Invest Dermatol, 556
- 2008, J Immunol, 756
- 2000, Respiration, 397
- 1993, Chest, 1051
- 1995, Proc Natl Acad Sci USA, 5239
- 2000, Br J Dermatol, 349
Cited by
Inflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 517
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Li, R., Li, J., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01722-y · Cited by 434
Molecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
“Most recently, autoantibodies against periplakin, a component of desmosomes within epithelium, were identified in patients with IPF, and were associated with worse physiologic parameters [172].”
BackgroundThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“A variety of novel autoantibodies targeting neoepitopes have been reported in IPF (159–163), with many of the targets being structural cell proteins, such as desmoplakin (164) and periplakin (159).”
BackgroundAntoniou, K. M., Margaritopoulos, G. A., Tomassetti, S., Bonella, F., Costabel, U., & Poletti, V. (2014) · European Respiratory Review · doi:10.1183/09059180.00009113 · Cited by 274
Metadata
- Authors
- Taillé, C., Grootenboer-Mignot, S., Boursier, C., Michel, L., Debray, M.-P., Fagart, J., Barrientos, L., Mailleux, A., Cigna, N., Tubach, F., Marchal-Sommé, J., Soler, P., Chollet-Martin, S., & Crestani, B.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Laboratoire d'Immunologie “Autoimmunité et Hypersensibilités,”
- Université Paris-Sud (FR)
- Hôpital Saint-Louis (FR)
- Service de Radiologie
- Inserm (FR)
- Unité 700 and
- Service de Pneumologie et Centre de Compétence des Maladies Pulmonaires Rares
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 759-766
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2105937700
- Cited by
- 120
- References
- 38
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 2 · 2023: 7 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 7 · 2018: 9 · 2017: 4 · 2016: 6 · 2015: 6 · 2014: 12 · 2013: 13 · 2012: 10
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- idiopathic pulmonary fibrosis, periplakin, autoantibodies, autoimmunity, alveolar epithelial cells, desmosomes, bronchoalveolar lavage, disease severity, T cell proliferation, epithelial wound repair, cell migration
- MeSH terms
- Adult, Aged, Autoantibodies, Female, Humans, Immunoglobulin G, Male, Middle Aged, Severity of Illness Index, Biomarkers, Autoimmunity, Case-Control Studies, Respiratory Mucosa, Plakins, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.201001-0076oc
- The paper
- Taillé, C., Grootenboer-Mignot, S., Boursier, C., Michel, L., Debray, M.-P., Fagart, J., Barrientos, L., Mailleux, A., Cigna, N., Tubach, F., Marchal-Sommé, J., Soler, P., Chollet-Martin, S., & Crestani, B. (2011). Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201001-0076oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.